217 related articles for article (PubMed ID: 31342358)
1. Sexual Dysfunction in Survivorship; the Impact of Menopause and Endocrine Therapy.
Kuehn R; Casaubon J; Raker C; Edmonson D; Stuckey A; Gass J
Ann Surg Oncol; 2019 Oct; 26(10):3159-3165. PubMed ID: 31342358
[TBL] [Abstract][Full Text] [Related]
2. Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy?
Gandhi C; Butler E; Pesek S; Kwait R; Edmonson D; Raker C; Clark MA; Stuckey A; Gass J
Am J Clin Oncol; 2019 Jun; 42(6):500-506. PubMed ID: 31094713
[TBL] [Abstract][Full Text] [Related]
3. Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?
Gass JS; Onstad M; Pesek S; Rojas K; Fogarty S; Stuckey A; Raker C; Dizon DS
Ann Surg Oncol; 2017 Oct; 24(11):3133-3140. PubMed ID: 28608119
[TBL] [Abstract][Full Text] [Related]
4. Assessment of sexuality among middle-aged women using the Female Sexual Function Index.
Chedraui P; Perez-Lopez FR; San Miguel G; Avila C
Climacteric; 2009 Jun; 12(3):213-21. PubMed ID: 19117186
[TBL] [Abstract][Full Text] [Related]
5. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.
Advani P; Brewster AM; Baum GP; Schover LR
J Cancer Surviv; 2017 Aug; 11(4):477-485. PubMed ID: 28229275
[TBL] [Abstract][Full Text] [Related]
6. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
[TBL] [Abstract][Full Text] [Related]
7. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Dorfman CS; Arthur SS; Kimmick GG; Westbrook KW; Marcom PK; Corbett C; Edmond SN; Shelby RA
Menopause; 2019 Aug; 26(8):823-832. PubMed ID: 30994574
[TBL] [Abstract][Full Text] [Related]
8. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Frechette D; Paquet L; Verma S; Clemons M; Wheatley-Price P; Gertler SZ; Song X; Graham N; Dent S
Breast Cancer Res Treat; 2013 Aug; 141(1):111-7. PubMed ID: 23942873
[TBL] [Abstract][Full Text] [Related]
9. Male and Female Sexual Dysfunction in Pediatric Cancer Survivors.
Greenberg DR; Khandwala YS; Bhambhvani HP; Simon PJ; Eisenberg ML
J Sex Med; 2020 Sep; 17(9):1715-1722. PubMed ID: 32622765
[TBL] [Abstract][Full Text] [Related]
10. Sexual function after breast cancer.
Panjari M; Bell RJ; Davis SR
J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
[TBL] [Abstract][Full Text] [Related]
11. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.
Baumgart J; Nilsson K; Evers AS; Kallak TK; Poromaa IS
Menopause; 2013 Feb; 20(2):162-8. PubMed ID: 22990756
[TBL] [Abstract][Full Text] [Related]
12. Relationship between sexual dysfunction and psychiatric status in premenopausal women with fibromyalgia.
Aydin G; Başar MM; Keleş I; Ergün G; Orkun S; Batislam E
Urology; 2006 Jan; 67(1):156-61. PubMed ID: 16413353
[TBL] [Abstract][Full Text] [Related]
13. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
[TBL] [Abstract][Full Text] [Related]
14. The effects of fractional microablative CO
Gittens P; Mullen G
J Cosmet Laser Ther; 2019; 21(3):127-131. PubMed ID: 29883233
[TBL] [Abstract][Full Text] [Related]
15. Sexual health in long-term breast cancer survivors.
Soldera SV; Ennis M; Lohmann AE; Goodwin PJ
Breast Cancer Res Treat; 2018 Nov; 172(1):159-166. PubMed ID: 30027300
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China.
Tong J; Zhang C; Zhu L; Zhang L; Jinghe L
Climacteric; 2019 Apr; 22(2):190-194. PubMed ID: 30572733
[TBL] [Abstract][Full Text] [Related]
17. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
Schover LR; Baum GP; Fuson LA; Brewster A; Melhem-Bertrandt A
J Sex Med; 2014 Dec; 11(12):3102-11. PubMed ID: 25141792
[TBL] [Abstract][Full Text] [Related]
18. The association between sexual dysfunction and metabolic syndrome among Turkish postmenopausal women.
Yoldemir T; Garibova N; Atasayan K
Climacteric; 2019 Oct; 22(5):472-477. PubMed ID: 30889983
[No Abstract] [Full Text] [Related]
19. Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role?
Alder J; Zanetti R; Wight E; Urech C; Fink N; Bitzer J
J Sex Med; 2008 Aug; 5(8):1898-906. PubMed ID: 18554258
[TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction among postmenopausal women.
Masliza W; Daud W; Yazid Bajuri M; Shuhaila A; Hatta S; Rohaizat Hassan M; Norzilawati MN
Clin Ter; 2014; 165(2):83-9. PubMed ID: 24770809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
